Cartilage biomarkers in hemodialysis patients and the effect of β2-microglobulin on articular chondrocytes

Osteoarthritis and Cartilage

Volumn 16, Issue 11, 2008, Pages 1336-1342

  Sunk, I G ^a   Demetriou, D ^a   Szendroedi, J ^b   Amoyo, L ^a   Raffetseder, A ^a   Horl W H ^a   Sunder Plassmann, G ^a   Smolen, J S ^a   Bobacz, K ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HANUSCH HOSPITAL   (Austria)

Author keywords

2 Microglobulin; Amyloidosis; Cartilage; Hemodialysis

Indexed keywords

BETA 2 MICROGLOBULIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; COLLAGEN; COLLAGEN TYPE 2; GELATINASE B; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; MESSENGER RNA; PROCOLLAGEN TYPE 2 CARBOXYPROPEPTIDE; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLOIDOSIS; ANIMAL CELL; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; CARBOHYDRATE SYNTHESIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL CULTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; COW; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOLAYER CULTURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ANIMALS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CATTLE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; HUMANS; MIDDLE AGED; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 53849147203     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.03.024     Document Type: Article

References (40)

1. Kart-Koseoglu H., Yucel A.E., Niron E.A., Koseoglu H., Isiklar I., and Ozdemir F.N. Osteoarthritis in hemodialysis patients: relationships with bone mineral density and other clinical and laboratory parameters. Rheumatol Int 25 (2005) 270-275
2. Abbott K.C., Bucci J.R., and Agodoa L.Y. Total hip arthroplasty in chronic dialysis patients in the United States. J Nephrol 16 (2003) 34-39
3. Fukuda K., and Yamamoto H. Dialysis-related amyloidosis. Semin Musculoskelet Radiol 5 (2001) 113-119
4. Bardin T. Arthropathy and carpal tunnel syndrome of β2-microglobulin amyloidosis. In: van Ypersele C., and Drueke T. (Eds). Dialysis Amyloid. Oxford Clinical Nephrology Series (1996), Oxford University Press, Oxford 71-97
5. Charra B., Calemard E., and Laurent G. Chronic renal failure treatment duration and mode: their relevance to the late dialysis periarticular syndrome. Blood Purif 6 (1988) 117-124
6. Jadoul M., Garbar C., Noel H., Sennesael J., Vanholder R., Bernaert P., et al. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int 51 (1997) 1928-1932
7. Sethi D., and Gower P.E. Synovial-fluid beta 2-microglobulin levels in dialysis arthropathy. N Engl J Med 315 (27 November 1986) 1419-1420
8. Athanasou N.A., Puddle B., and Sallie B. Highly sulphated glycosaminoglycans in articular cartilage and other tissues containing beta 2 microglobulin dialysis amyloid deposits. Nephrol Dial Transplant 10 (1995) 1672-1678
9. Inoue S., Kuroiwa M., Ohashi K., Hara M., and Kisilevsky R. Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. Kidney Int 52 (1997) 1543-1549
10. Moe S.M., and Chen N.X. The role of the synovium and cartilage in the pathogenesis of beta(2)-microglobulin amyloidosis. Semin Dial 14 (2001) 127-130
11. Ohishi H., Skinner M., Sato-Araki N., Okuyama T., Gejyo F., Kimura A., et al. Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin Chem 36 (1990) 88-91
12. Relini A., Canale C., De Stefano S., Rolandi R., Giorgetti S., Stoppini M., et al. Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem 281 (16 June 2006) 16521-16529
13. Garbar C., Jadoul M., Noel H., and van Ypersele dS. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int 55 (1999) 1983-1990
14. van Ypersele De S.C., Jadoul M., and Garbar C. Morphogenesis of joint beta 2-microglobulin amyloid deposits. Nephrol Dial Transplant 16 Suppl 4 (2001) 3-7
15. Athanasou N.A. Description, localization, and progression of B2-microglobulin dialysis-related amyloid deposition. In: van Ypersele C., and Drueke T. (Eds). Dialysis Amyloid. Oxford Clinical Nephrology Series (1996), Oxford Press, Oxford 176-182
16. Gielen J.L., van Holsbeeck M.T., Hauglustaine D., Verresen L., Verbeken E., Baert A.L., et al. Growing bone cysts in long-term hemodialysis. Skeletal Radiol 19 (1990) 43-49
17. Kuntz D., Naveau B., Bardin T., Drueke T., Treves R., and Dryll A. Destructive spondylarthropathy in hemodialyzed patients. A new syndrome. Arthritis Rheum 27 (1984) 369-375
18. Ohashi K. Pathogenesis of beta2-microglobulin amyloidosis. Pathol Int 51 (2001) 1-10
19. Cobby M.J., Adler R.S., Swartz R., and Martel W. Dialysis-related amyloid arthropathy: MR findings in four patients. AJR Am J Roentgenol 157 (1991) 1023-1027
20. Ayers D.C., Athanasou N.A., Woods C.G., and Duthie R.B. Dialysis arthropathy of the hip. Clin Orthop Relat Res (1993) 216-224
21. Lohmander L.S., Ionescu M., Jugessur H., and Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 42 (1999) 534-544
22. Clark A., Jordan J., Vilim V., Renner J., Dragomir A., Luta G., et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project. Arthritis Rheum 42 (1999) 2356-2364
23. Vilim V., Olejarova M., Machacek S., Gatterova J., Kraus V., and Pavelka K. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10 (2002) 707-713
24. Cahue S., Sharma L., Dunlop D., Ionescu M., Song J., Lobanok T., et al. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage (5 March 2007)
25. Huebner J.L., and Kraus V.B. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 14 (2006) 923-930
26. Oliveria S.A., Felson D.T., Reed J.I., Cirillo P.A., and Walker A.M. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 38 (1995) 1134-1141
27. Conrozier T., Ferrand F., Poole A.R., Verret C., Mathieu P., Ionescu M., et al. Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies. Osteoarthritis Cartilage 15 (2007) 462-467
28. Erlacher L., Ng C.K., Ullrich R., Krieger S., and Luyten F.P. Presence of cartilage-derived morphogenetic proteins in articular cartilage and enhancement of matrix replacement in vitro. Arthritis Rheum 41 (1998) 263-273
29. Gejyo F., Homma N., Suzuki Y., and Arakawa M. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 314 (27 February 1986) 585-586
30. Bobacz K., Gruber R., Soleiman A., Graninger W.B., Luyten F.P., and Erlacher L. Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed in healthy and osteoarthritic human articular chondrocytes and stimulate matrix synthesis. Osteoarthritis Cartilage 10 (2002) 394-401
31. Labarca C., and Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102 (1 March 1980) 344-352
32. Nishimura R., Bowolaksono A., Acosta T.J., Murakami S., Piotrowska K., Skarzynski D.J., et al. Possible role of interleukin-1 in the regulation of bovine corpus luteum throughout the luteal phase. Biol Reprod 71 (2004) 1688-1693
33. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J., et al. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 16 (1998) 483-496
34. Ohashi K., Kawai R., Hara M., Okada Y., Tachibana S., and Ogura Y. Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis. Virchows Arch 428 (1996) 37-46
35. Migita K., Eguchi K., Tominaga M., Origuchi T., Kawabe Y., and Nagataki S. Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts. Biochem Biophys Res Commun 239 (20 October 1997) 621-625
36. Moe S.M., Singh G.K., and Bailey A.M. Beta2-microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts. Kidney Int 57 (2000) 2023-2034
37. Zhang H., Liew C.C., and Marshall K.W. Microarray analysis reveals the involvement of beta-2 microglobulin (B2M) in human osteoarthritis. Osteoarthritis Cartilage 10 (2002) 950-960
38. Ebihara I., Nakamura T., Tomino Y., Shimada N., and Koide H. Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure. Am J Nephrol 18 (1998) 305-310
39. Preston G.A., Barrett C.V., Alcorta D.A., Hogan S.L., Dinwiddie L., Jennette J.C., et al. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron 92 (2002) 817-823
40. Borysik A.J., Morten I.J., Radford S.E., and Hewitt E.W. Specific glycosaminoglycans promote unseeded amyloid formation from beta(2)-microglobulin under physiological conditions. Kidney Int 72 (2007) 174-181